DATA-DRIVEN SUBTYPING AND POST HOC ANALYSIS OF AZD0530 (FYN) TRIAL (ID 2394)

Presenter
Authors
Gallery Display
Onsite Oral and Gallery PDF
Audio MP3

Audio MP3

Hide

Previous ePoster
VISIT-TO-VISIT BLOOD PRESSURE VARIABILITY PREDICTS CEREBROSPINAL FLUID ALZHEIMER’S DISEASE BIOMARKERS IN OLDER ADULTS (ID 2317)

Next ePosters
COGNITIVE SCREENING IN PATIENTS WITH PARKINSONISM: PROPOSAL FOR A NEW, MACHINE LEARNING-BASED DIAGNOSTIC TOOL (ID 2396)
ASSOCIATIONS BETWEEN IRON DEPOSITION IN THE BRAIN AND AD-LIKE NEUROIMAGING PHENOTYPES IN COGNITIVELY UNIMPAIRED ADULTS (ID 2471)
TARGETING REACTIVE ASTROCYTOSIS FOR NOVEL BIOMARKERS OF DISEASE SEVERITY IN MULTIPLE SYSTEM ATROPHY (ID 2359)
PARKINSON’S DISEASE MODIFICATION THROUGH ABL KINASE INHIBITION (ID 2360)
PROTEOMIC CORRELATES OF AMYLOID BETA AND TAU IN CSF. A MONOZYGOTIC TWIN STUDY (ID 2408)
GSK-3ALPHA IN HUNTINGTON’S DISEASE (ID 1797)
UNDERSTANDING SYNAPTIC INTEGRITY IN ALZHEIMER’S BRAIN WITH UCB-J (ID 2266)
MOLECULAR COMPOSITION OF ENTORHINAL SYNAPSES IN PRIMARY AGE-RELATED TAUOPATHY AND ALZHEIMER’S DISEASE (ID 2267)
INCREASED SV2A-PET AND EXCITATORY POSTSYNAPTIC POTENTIAL CORRELATES WITH RELEASE OF CSF NEUROGRANIN AND TAU IN APP KNOCK-IN MICE (ID 2268)
CHRONIC IN VIVO ALTERATIONS OF AΗ-Α PEPTIDE LEVELS PERTURB SYNAPTIC PLASTICITY AND IMPACT SPATIAL MEMORY. (ID 2271)